Bohle W, Ruether U, Rassweiler J, Nunnensiek C, Eisenberger F, Jipp P
Department of Internal Medicine, Katharinenhospital, Stuttgart, Germany.
Urol Int. 1997;59(1):53-4. doi: 10.1159/000283019.
Single-agent carboplatin chemotherapy has recently been introduced into the therapy of limited seminoma. Because of poor compliance due to Down's syndrome we successfully treated a 32-year-old man with relapsed stage-IIIB seminoma with a dose-modified carboplatin monotherapy schedule leading to complete remission even after a follow-up of 4 years.
单药卡铂化疗最近已被引入局限性精原细胞瘤的治疗。由于唐氏综合征导致依从性差,我们成功地用剂量调整的卡铂单药治疗方案治疗了一名32岁复发的IIIB期精原细胞瘤男性患者,即使在随访4年后也实现了完全缓解。